Pediatrix Medical Group, Inc. (MD)
NYSE: MD · IEX Real-Time Price · USD
9.24
-0.16 (-1.70%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Pediatrix Medical Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,995 | 1,972 | 1,911 | 1,734 | 1,780 | 1,723 | 3,253 | 3,183 | 2,780 | 2,439 | Upgrade
|
| Revenue Growth (YoY) | 1.15% | 3.18% | 10.22% | -2.57% | 3.29% | -47.04% | 2.21% | 14.50% | 13.99% | 13.23% | Upgrade
|
| Cost of Revenue | 1,573 | 1,505 | 1,398 | 1,285 | 1,277 | 1,218 | 2,334 | 2,150 | 1,852 | 1,632 | Upgrade
|
| Gross Profit | 421.57 | 467.03 | 513.24 | 449.32 | 503.09 | 504.96 | 919.61 | 1,034 | 928.01 | 806.52 | Upgrade
|
| Selling, General & Admin | 227.54 | 231.4 | 263.36 | 248.95 | 244.51 | 232.22 | 385.86 | 372.57 | 305.92 | 247.53 | Upgrade
|
| Other Operating Expenses | 186.7 | 62.95 | 46.97 | 102.24 | 86.82 | 24.36 | 78.86 | 89.26 | 64.23 | 45.99 | Upgrade
|
| Operating Expenses | 414.24 | 294.35 | 310.32 | 351.19 | 331.33 | 256.57 | 464.72 | 461.84 | 370.14 | 293.52 | Upgrade
|
| Operating Income | 7.32 | 172.69 | 202.92 | 98.13 | 171.76 | 248.39 | 454.89 | 571.69 | 557.87 | 513 | Upgrade
|
| Interest Expense / Income | 42.08 | 39.7 | 68.72 | 110.48 | 118.93 | 92.95 | 74.56 | 63.09 | 23.11 | 8.89 | Upgrade
|
| Other Expense / Income | 13.61 | 47.85 | -24.01 | 767.41 | 1,534 | -157.88 | -20.27 | -5.52 | -5.6 | -4.59 | Upgrade
|
| Pretax Income | -48.36 | 85.14 | 158.21 | -779.76 | -1,481.13 | 313.32 | 400.6 | 514.12 | 540.36 | 508.69 | Upgrade
|
| Income Tax | 12.05 | 18.81 | 27.24 | 16.73 | 16.58 | 44.69 | 80.23 | 189.2 | 204.04 | 191.41 | Upgrade
|
| Net Income | -60.41 | 66.34 | 130.96 | -796.49 | -1,497.7 | 268.63 | 320.37 | 324.91 | 336.32 | 317.28 | Upgrade
|
| Net Income Growth | - | -49.35% | - | - | - | -16.15% | -1.40% | -3.39% | 6.00% | 13.11% | Upgrade
|
| Shares Outstanding (Basic) | 82 | 83 | 85 | 83 | 83 | 91 | 92 | 92 | 93 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 82 | 84 | 86 | 83 | 84 | 92 | 93 | 93 | 94 | 100 | Upgrade
|
| Shares Change | -2.28% | -1.99% | 2.92% | -0.73% | -8.29% | -1.45% | -0.16% | -0.91% | -5.93% | -1.07% | Upgrade
|
| EPS (Basic) | -0.73 | 0.79 | 1.54 | -9.44 | -18.44 | 2.95 | 3.47 | 3.52 | 3.61 | 3.22 | Upgrade
|
| EPS (Diluted) | -0.73 | 0.74 | 1.26 | -0.11 | 0.50 | 1.33 | 3.29 | 3.49 | 3.58 | 3.18 | Upgrade
|
| EPS Growth | - | -41.27% | - | - | -62.41% | -59.57% | -5.73% | -2.51% | 12.58% | 14.39% | Upgrade
|
| Free Cash Flow | 104 | 137.23 | 69.22 | 175.83 | 338.44 | 296.59 | 485.23 | 404.51 | 341.63 | 404.58 | Upgrade
|
| Free Cash Flow Per Share | 1.26 | 1.64 | 0.82 | 2.11 | 4.05 | 3.25 | 5.25 | 4.38 | 3.67 | 4.10 | Upgrade
|
| Gross Margin | 21.13% | 23.68% | 26.85% | 25.91% | 28.27% | 29.31% | 28.27% | 32.47% | 33.38% | 33.07% | Upgrade
|
| Operating Margin | 0.37% | 8.76% | 10.62% | 5.66% | 9.65% | 14.42% | 13.98% | 17.96% | 20.07% | 21.03% | Upgrade
|
| Profit Margin | -3.03% | 3.36% | 6.85% | -45.93% | -84.15% | 15.59% | 9.85% | 10.21% | 12.10% | 13.01% | Upgrade
|
| Free Cash Flow Margin | 5.21% | 6.96% | 3.62% | 10.14% | 19.02% | 17.21% | 14.91% | 12.71% | 12.29% | 16.59% | Upgrade
|
| Effective Tax Rate | - | 22.09% | 17.22% | - | - | 14.26% | 20.03% | 36.80% | 37.76% | 37.63% | Upgrade
|
| EBITDA | 29.89 | 160.47 | 259.07 | -640.84 | -1,336.27 | 430.62 | 554.02 | 666.47 | 627.7 | 563.58 | Upgrade
|
| EBITDA Margin | 1.50% | 8.14% | 13.56% | -36.96% | -75.08% | 24.99% | 17.03% | 20.94% | 22.58% | 23.11% | Upgrade
|
| Depreciation & Amortization | 36.17 | 35.64 | 32.15 | 28.44 | 25.93 | 24.36 | 78.86 | 89.26 | 64.23 | 45.99 | Upgrade
|
| EBIT | -6.28 | 124.84 | 226.93 | -669.28 | -1,362.2 | 406.27 | 475.16 | 577.21 | 563.47 | 517.59 | Upgrade
|
| EBIT Margin | -0.32% | 6.33% | 11.87% | -38.60% | -76.54% | 23.58% | 14.61% | 18.13% | 20.27% | 21.22% | Upgrade
|